Medable provides a unified clinical trial platform and eCOA/ePRO solutions to streamline data collection, site engagement, and decentralized trials across a global network. The company emphasizes agentic AI capabilities to automate trial tasks, improve adherence, and accelerate timelines, with deployments in over 60 countries and 120 languages. Its offerings cover eCOA, remote data capture, consent, and site experiences, positioning it as a leader in modern, patient-centric clinical research. Headquartered in Palo Alto, California, Medable serves biopharma sponsors and CROs seeking faster, higher-quality trial outcomes.
No recent deals for this company.